Article
Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation.
Cardiovascular research - 1 May 2010
Furgeson Seth B, Simpson Peter A, Park Insun, Vanputten Vicki, Horita Henrick, Kontos Christopher D, Nemenoff Raphael A, Weiser-Evans Mary C M
Abstract excerpt
AIMS: Phosphatase and tensin homolog (PTEN) is implicated as a negative regulator of vascular smooth muscle cell (SMC) proliferation and injury-induced vascular remodelling. We tested if selective depletion of PTEN only in SMC is sufficient to promote SMC phenotypic modulation, cytokine production, and enhanced neointima formation. METHODS AND RESULTS: Smooth muscle marker expression and induction of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
